Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Insulin-like growth factor-II/mannose-6-phosphate receptor expression during early heart development. Dev Dyn 1996 Oct;207(2):195-203

Date

10/01/1996

Pubmed ID

8906422

DOI

10.1002/(SICI)1097-0177(199610)207:2<195::AID-AJA7>3.0.CO;2-C

Scopus ID

2-s2.0-0029853236 (requires institutional sign-in at Scopus site)   8 Citations

Abstract

Expression of the insulin-like growth factor-II/mannose-6-phosphate (ICF-II/ M6P) receptor was examined during the major stages of heart morphogenesis in the chicken embryo. By using an affinity-purified antibody, Western blot analysis of total embryonic proteins from stages 5-24 revealed little if any IGF-II/M6P receptor protein until stage 7, approximately 8 hours prior to the appearance of the rudimentary myocardial tubes. Thereafter, receptor accumulation increased until stage 14, after which receptor protein levels remained constant, up to 7 days in ovo. Immunohistochemical localization revealed that, among all embryonic tissues at stages 10-24, the predominant site of receptor expression was the developing myocardium. Receptor expression was also immunohistochemically evaluated in a defined in vitro model of cardiogenesis in which explanted precardiac mesoderm is induced to undergo differentiation by co-explanted endoderm. In this system, as in vivo, IGF-II/M6P receptors were only detected after precardiac mesoderm had differentiated into a synchronously contractile multilayer which expressed cardiac alpha-actin. These findings indicate that the IGF-II/M6P receptor has an important role during early heart development.

Author List

McCormick KM, Dahms NM, Lough J

Authors

Nancy M. Dahms PhD Professor in the Biochemistry department at Medical College of Wisconsin
John W. Lough PhD Professor in the Cell Biology, Neurobiology and Anatomy department at Medical College of Wisconsin




MESH terms used to index this publication - Major topics in bold

Animals
Blotting, Western
Chick Embryo
Fluorescent Antibody Technique, Indirect
Heart
Myocardium
Receptor, IGF Type 2